Project Grant HT94252310772
Award Date
8/15/23
Completion Date
8/14/27
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The University of Oklahoma Health Sciences Center was awarded a $541,837 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Drug-Targeting ORP4 as a Precision Ovarian Cancer Target". The award period runs from May 1, 2025 to April 30, 2029. The research aims to advance disease prevention, diagnosis, treatment, and management of ovarian cancer through basic, applied, and translational research...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,144,000.00 to the University of Oklahoma Health Sciences Center to conduct research on "DRUG-TARGETING ORP4 AS A PRECISION OVARIAN CANCER TARGET". The 4-year award, which began on May 1, 2025, supports advanced biomedical research focused on transforming healthcare for military service members and the general public. The research project aims...
The University of Oklahoma Health Sciences Center was awarded an $864,781 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from April 1, 2023 to March 31, 2026 targeting DCLK1-driven chemoresistance in ovarian cancer. The goal aligns with the Military Medical Research and Development program's focus on innovative medical solutions for Service Members and the public through...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $427,109.00 to the University of Oklahoma Health Sciences Center to conduct research targeting DCLK1-mediated glutamine addiction in chemoresistant ovarian cancer metastases. The research aims to transform healthcare for military service members and the public by advancing disease prevention, diagnosis, treatment, and management through translational...
The University of Oklahoma Health Sciences Center Division has been awarded a $144,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, will support advanced biomedical research focused on "Vascular Regulation of Immunosuppression in Glioblastoma." The funding will enable the university to conduct...
The University of Oklahoma Health Sciences Center was awarded a $1,285,344 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the development and preliminary evaluation of a tailored mHealth app designed to improve quality-of-life outcomes in prostate cancer survivors. The project includes a subaward to the Mayo Clinic and will run from July 2024 to July 2027. The grant aims...
The University of Oklahoma's Health Sciences Center Division was awarded a $717,750 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate one-carbon metabolic alterations to target pancreatic cancer cachexia. The research effort aims to develop new treatments and improve patient care for this condition, which is a major concern for service members and veterans. The three-year project will be conducted in Oklahoma City,...
This federal Project Grant award of $2,131,863.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Oklahoma Health Sciences Center to explore expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to advance medical solutions for military service members and the broader public through innovative and impactful basic, applied, and translational research over the award period from...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
The University of Oklahoma (OU) was awarded a $195,943 Project Grant by the Air Force Research Laboratory (AFRL) under the Air Force Defense Research Sciences Program (CFDA 12.800). The grant, which runs from April 15, 2025 to April 14, 2027, supports research on "Evolving Infrared Technologies: Next-Generation IR Tunable Smart Structures." As a leading research institution, OU will leverage its expertise in atmospheric sciences, engineering, and other relevant fields to advance...